Effects of Beverage Volume, Glycerol Concentration, and Sodium Concentration on Fluid Balance in Healthy Euhydrated Men and Women at Rest
Public ClinicalTrials.gov record NCT06854471. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The presence of certain ingredients such as sodium and glycerol can facilitate retention of the fluid consumed via renal water reabsorption. To maintain overall whole-body fluid balance, it is important that ingested fluid is retained in the body instead of losing it through urination. The purpose of this study is to determine the effect of sodium and glycerol concentrations at various fluid intake volumes on fluid balance in healthy, euhydrated men and women.
Study identification
- NCT ID
- NCT06854471
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- Placebo beverage, kiwi-strawberry flavor Other
- Electrolyte solution without glycerol beverage 1 Other
- Electrolyte solution without glycerol beverage 2 Other
- Electrolyte solution without glycerol beverage 3 Other
- Electrolyte solution with glycerol beverage 1 Other
- Electrolyte solution with glycerol beverage 2 Other
- Electrolyte solution with glycerol beverage 3 Other
- Base with glycerol, no electrolytes beverage 1 Other
- Base with glycerol, no electrolytes beverage 2 Other
- Base with glycerol, no electrolytes beverage 3 Other
Other
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 8, 2025
- Primary completion
- Dec 14, 2025
- Completion
- Dec 14, 2025
- Last update posted
- Jul 16, 2025
2025
United States locations
- U.S. sites
- 3
- U.S. states
- 2
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| IMG Academy/GSSI Bradenton Gatorade Sports Science Institute | Bradenton | Florida | 34210 | Recruiting |
| GCP Research | St. Petersburg | Florida | 33705 | Recruiting |
| Gatorade Sports Science Institute | Valhalla | New York | 10595 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06854471, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 16, 2025 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06854471 live on ClinicalTrials.gov.